3 min.
Up till now, there is no treatment that specifically targets the NRAS mutated melanoma, although MEK-inhibition shows some effect. Prof. Rutao Cui is developing a new therapeutic strategy, targeting up and downstream signaling pathways for NRAS mutated melanoma.